Previous Article | Next Article 
Infect Immun, July 1998, p. 3242-3249, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
In Vitro Cellular Toxicity Predicts
Pseudomonas aeruginosa Virulence in Lung
Infections
Teiji
Sawa,1
Maria
Ohara,1
Kiyoyasu
Kurahashi,1
Sally S.
Twining,2
Dara W.
Frank,3
David B.
Doroques,1
Taicy
Long,1
Michael A.
Gropper,1 and
Jeanine
P.
Wiener-Kronish1,*
Departments of Anesthesia and Medicine,
Cardiovascular Research Institute, The University of California,
San Francisco, California 94143,1 and
Department of Biochemistry2 and
Department of Microbiology,3 Medical
College of Wisconsin, Milwaukee, Wisconsin 53226
Received 21 January 1998/Returned for modification 30 March
1998/Accepted 29 April 1998
 |
ABSTRACT |
The role of quorum sensing by Pseudomonas aeruginosa in
producing cytotoxicity has not been fully investigated. Strains of P. aeruginosa have been characterized as having an invasive
or a cytotoxic phenotype (S. M. J. Fleiszig et al., Infect.
Immun. 65:579-586, 1997). We noted that the application of a large
inoculum of the invasive strain 6294 caused cytotoxicity of cultured
epithelial cells. To investigate this dose-related cytotoxicity, we
compared the behavior of 6294 to that of another invasive strain, PAO1, and determined whether the cytotoxicity could be related to quorum sensing. Both invasive strains, 6294 and PAO1, appear to have quorum-sensing systems that were operative when large doses of bacteria
were applied to cultured lung epithelial cells or instilled into the
lungs of animals. Nonetheless, only 6294 was cytotoxic. Cytotoxicity
induced by 6294 correlated with increased elastase production. These
experiments suggest that there are multiple mechanisms for the
induction of cytotoxicity, pathology, and mortality in vivo. However,
in vivo cytotoxicity and mortality, but not pathology, could be
predicted by quantitative in vitro cellular damage experiments
utilizing a range of bacteria-to-cell ratios. It appears that quorum
sensing may inversely correlate with virulence in that strains that
produced PAI [N-(3-oxododecanoyl) homoserine lactone]
also appeared to attract more polymorphonuclear leukocytes in vivo and
were possibly eliminated more quickly. In addition, exoproduct
production in bacteriological medium in vitro may differ significantly
from exoproduct expression from infections in vivo or during
cocultivation of bacteria with tissue culture cells.
 |
INTRODUCTION |
Pseudomonas aeruginosa
lung infections occur frequently in critically ill patients (8,
26, 27). Patients who are mechanically ventilated are especially
at high risk for developing P. aeruginosa pneumonia (1,
4, 30). Mortality rates are higher in patients who have
ventilator-associated pneumonia (VAP) than in patients who do not
develop VAP (7, 34). In addition, the mortality rate of
patients with VAP due to P. aeruginosa is significantly higher than the mortality rate associated with VAP secondary to other
bacteria (9). P. aeruginosa pneumonia is
frequently associated with the development of septic shock and multiple
organ failure which are also correlated with high mortality rates
(1, 22, 29).
The high mortality rate of P. aeruginosa pneumonia may be
secondary to the ability of some of the P. aeruginosa
strains to cause necrosis of the lung epithelium and to disseminate
into the circulation rapidly (17, 32, 33). Recently,
different strains of P. aeruginosa have been characterized
as having either an invasive or a cytotoxic phenotype (11, 12,
25). Cytotoxic strains cause necrosis of epithelial cells in
vitro and in vivo (11, 12, 25). We recently reported that
the ability to induce acute cytotoxicity is associated with the
expression of ExoU, a type III secretory cytotoxin regulated by the
transcriptional activator ExsA (10). Invasive strains were
found to lack exoU (10).
Although the expression of ExoU has been linked to cytotoxicity,
P. aeruginosa synthesizes several extracellular virulence determinants which may contribute to either cytotoxicity or invasion. Many exoproducts of P. aeruginosa, such as elastase (LasB),
LasA protease, alkaline protease, and exotoxin A, are not actively produced until bacterial cell density reaches a threshold concentration (15, 16). One mechanism by which bacteria respond to changes in cell density is explained as the cell density-dependent
transcriptional regulation often called a quorum-sensing system
(14, 23). The LasR-LasI system is one of the quorum-sensing
systems found in P. aeruginosa and shows homology to the
LuxR-LuxI system of V. fischeri (15, 16, 23). In
this quorum-sensing system, LasI (autoinducer synthase) directs the
synthesis of the autoinducer PAI-1 [N-(3-oxododecanoyl)
homoserine lactone], which triggers a transcriptional activator, LasR,
to induce virulence genes such as lasB, lasA, and
toxA (16). In addition, P. aeruginosa
possesses a second quorum-sensing system, the RhlR-RhlI system, which
regulates rhamnolipid and LasB production (2, 19). PAO1, a
P. aeruginosa strain classified as an invasive strain
due to the lack of exoU (10, 13), has the
LasR-LasI system (23) and the RhlR-RhlI system (2,
19). Cell density-dependent virulence regulatory systems also
appear to be involved in the pathogenesis of bacterial dissemination
and in causing the mortality associated with P. aeruginosa
pneumonia (28).
In the present study, we investigated the cell density-dependent
cytotoxicity and lung epithelial injury caused by two invasive P. aeruginosa strains. We found differences among the two invasive strains investigated, 6294 and PAO1, suggesting that quorum-sensing systems may be involved in the production of density-dependent cytotoxicity.
 |
MATERIALS AND METHODS |
Bacterial strains and preparation.
P. aeruginosa PA103
is a cytotoxic strain (12, 17). PAO1 was generously provided
by Barbara Iglewski (University of Rochester, Rochester, N.Y.). Strain
6294 was generously provided by Suzanne Fleiszig (University of
California, Berkeley, Calif.). The genotypic details of these strains
were described previously (10, 12, 17); in brief, PA103
expresses ExoU and is cytotoxic at a relatively low initial bacterial
density, whereas 6294 and PAO1 are not cytotoxic (do not possess
exoU) at a similar bacterial density. These strains were
stored as bacterial stocks at
70°C in 10% sterile skim milk solutions. Bacteria from these frozen stocks were streaked onto Trypticase soy agar plates and grown in a deferrated dialysate of
Trypticase soy broth supplemented with 10 mM nitrilotriacetic acid
(Sigma Chemical Co., St. Louis, Mo.), 1% glycerol, and 100 mM
monosodium glutamate at 33°C for 13 h in a shaking incubator. Cultures were centrifuged at 8,500 × g for 5 min, and
the bacterial pellet was washed three times in Ringer's lactate
solution and diluted into the appropriate number of CFU per milliliter
in Ringer's lactate solution as determined by spectrophotometry. The
numbers of bacteria were confirmed by determining CFU of diluted
aliquots on sheep blood agar plates.
In vitro cytotoxicity assay.
A human bronchial epithelial
cell line, immortalized by simian virus 40 (SV40) (BEAS-2B, ATCC
CRL9609) was cultured in Dulbecco's modified Eagle's medium H-16 with
10% heat-inactivated fetal calf serum, penicillin, and streptomycin;
the cells were kept in an incubator in 5% CO2. When the
cells reached confluence, 2 × 104 cells were
transferred to 96-well tissue culture plates and incubated overnight.
The following day, one of the three different P. aeruginosa strains (PA103, PAO1, or 6294) was mixed with medium (not containing antibiotics) and applied to the cells for a 6-h interval. Three different inocula (109, 107, and
105 CFU/ml) were applied. Cytotoxicity was quantitated by
measuring the production of lactate dehydrogenase (LDH) by using a
cytotoxicity assay kit (Cytotox 96; Promega, Madison, Wis.).
Infection of mice with three different strains.
All animal
experiments were performed in compliance with and with the approval of
the Animal Care Committee of the University of California, San
Francisco. The mice were briefly anesthetized with inhaled
methoxyflurane (Methofane; Pitman-Moore, Mundelein, Ill.) and were
placed in a supine position at a head-up angle of approximately 30°.
For each mouse, 50 µl of a bacterial inoculum was instilled slowly
into the left lobe of the lung with a gavage needle (modified animal
feeding needle, 24 G; Popper & Sons, Inc., New Hyde Park, N.Y.)
inserted into the trachea via the mouth. The proper insertion of the
needle was confirmed by observing the movement of the solution inside
the syringe during the animal's respiratory efforts. The weight of the
syringe was measured prior to and after the tracheal instillation to
confirm the volume instilled into each mouse.
Measurement of lung epithelial permeability and lung edema after
P. aeruginosa instillation.
The lung instillate was a
combination of 0.05 µCi of 125I-labeled human serum
albumin (Merck-Frosst, Quebec, Canada), 5 µg of anhydrous Evan's
blue, and 5% mouse albumin in 50 µl of Ringer's lactate solution
with an appropriate quantity of the specified P. aeruginosa.
The total radioactivity (cpm) in the instillate was measured with a
gamma radiation counter (Auto-Gamma, model 5550; Packard, Downers
Grove, Ill.). The 50-µl instillate was always instilled into the left
lobe of the lung of each anesthetized mouse. After 4 h, mice were
reanesthetized with pentobarbital (2.0 mg, intraperitoneal), and blood
was collected by carotid arterial puncture. Sternotomies were performed
after additional pentobarbital was administered. All pleural fluid was
collected in sterile containers. The lungs, tracheas, oropharynxes,
stomachs, and livers were harvested, and the levels of radioactivity of these samples were measured. The quantity of 125I-albumin
that had entered circulation was calculated by multiplying the counts
measured in the terminal blood sample (per milliliter) times the blood
volume (body weight × 0.07). Lungs were homogenized and placed in
preweighed aluminum pans and dried in an oven at 80°C for 3 days to
calculate the wet weight to dry weight ratios of the lungs (wet/dry
ratios) as previously described (17, 32, 33). The wet/dry
ratio is a well-accepted index of lung edema (32).
Bacterial culture in the lungs, livers, and pleural fluid samples
from infected mice.
The lungs were homogenized in sterile
containers with sterile water. Lung homogenates were sequentially
diluted and placed on sheep blood agar plates for a assessment of the
bacterial numbers in the lungs. Similarly, the livers were homogenized
and samples of the homogenate were diluted and plated on agar plates
for quantitative culture. Pleural fluids were cultured directly onto
blood agar plates. The lowest sensitivity limits of the bacteriological
tests were 10 CFU/ml of blood and 100 CFU/g of liver.
Histopathological analysis.
Inocula (50 µl of instillate
without bacteria or with PA103, PAO1, or 6294) were instilled into the
lungs at three different concentrations (105,
107, 109 CFU/ml). Four hours after
instillation, the lungs were perfused with 10% buffered formalin
phosphate for fixation and embedded in paraffin. Mounted sections were
stained with hematoxylin-eosin.
Analysis for quorum-sensing modules (autoinducer bioassay).
To measure the autoinducer production by the three different P. aeruginosa strains, bioassays for the autoinducer PAI-1 were performed as previously reported (24). Overnight cultures of Escherichia coli MG4 (a generous gift from E. P. Greenberg, University of Iowa, Iowa City) containing a plasmid with a
lasR and lasB::lacZ transcriptional fusion in a conditioned medium were diluted in supplemented A medium to an optical density at 660 nm of 0.1 and stored
on ice. Each bioassay consisted of 2 ml of the cell suspension plus a
test sample. After 5.5 h at 30°C,
-galactosidase activity was
measured as described by Miller (21). The activities of the
autoinducer in the following samples were tested: (i) bacterial culture
medium (a deferrated dialysate of Trypticase soy broth supplemented
with 10 mM nitrilotriacetic acid [Sigma Chemical], 1% glycerol, and
100 mM monosodium glutamate) in which each of the three different
P. aeruginosa strains were grown at 33°C for 13 h in
a shaking incubator and (ii) cell culture medium (DME-H16 with 10%
heat-inactivated fetal calf serum) in which human bronchial cells
(BEAS-2B) (106 cells/ml) were cultured with the three
different P. aeruginosa strains at three different bacterial
concentrations (109, 107, and 105
CFU/ml). Samples were filtered (pore size, 2 µm) and mixed with 2 ml
of a suspension of MG4 at the designated ratios.
Zymography and gel overlays.
Zymography was carried out with
nonreducing sodium dodecyl sulfate (SDS)-8% polyacrylamide gels
(Bio-Rad, Hercules, Calif.) containing gelatin (0.2%; Sigma Chemical
Co.) as previously described (31). Briefly, medium
conditioned with or without BEAS cells, BEAS cells plus PA103, PAO1, or
6294, or bacteria alone were applied to gels at a 1:1 ratio with sample
buffer without reducing agents or boiling. Sample size was determined
based on the amount of broth required to visualize the proteolytic
activity without diffusion into adjacent lanes. The samples were
electrophoresed under standard conditions (31). After
electrophoresis, SDS was removed from the gels by using an aqueous
solution containing 2.5% Triton X-100 (Sigma Chemical Co.). The gels
were subsequently incubated for 18 h in 50 mM Tris buffer, pH 8.0, containing 1 mM CaCl2, 1 µM ZnCl2, and 150 mM
NaCl. Proteolytic activity from separated bands was visualized by
staining the gels with Coomassie brilliant blue. Elastase and alkaline
proteinase were used as standards for identification of proteinases.
Molecular weight standards were reduced with dithiothreitol prior to
application to the gels. Apparent molecular weights were calculated
relative to these standards by using the program SigmaGel (SPSS,
Chicago, Ill.). All gel assays were repeated at least three times with
similar results.
Western blots.
Samples were electrophoresed with 5%
dithiothreitol in the sample buffer by being boiled on SDS-8%
polyacrylamide gels (18). The proteins were electroblotted
to nitrocellulose (Schleicher and Scheuell, Keene, N.H.), probed with a
rabbit polyclonal antibody to elastase (a gift from B. Iglewski),
washed, and subsequently incubated with a horseradish
peroxidase-conjugated goat anti-rabbit immunoglobulin G (3).
Bands were visualized with the chemiluminescence ECL kit (Amersham,
Arlington Heights, Ill.).
Statistical analysis.
Fisher's exact test was used for
comparison of bacteriological data. The Mantel-Cox log rank test was
used for survival analysis. One-way analysis of variance and the
Bonferroni multiple comparison test were used for all other
comparisons. Significance was accepted at P < 0.05.
 |
RESULTS |
In vitro cytotoxicity assay.
In previous studies we have
correlated the ability to induce acute cytotoxicity in vitro with the
expression of ExoU. Under these conditions, cytotoxicity was observed
with relatively low bacterial inocula and during a short cocultivation
period (3 h). To determine if ExoU-independent cytotoxicity was
detectable, we compared the cytotoxic responses of three different
P. aeruginosa strains, PA103 (exoU+),
PAO1 (exoU), and 6294 (exoU) to that of human
bronchial cells immortalized by SV40 (BEAS-2B) (Fig.
1). A low concentration (105
CFU/ml) of PA103 did not show cytotoxicity. Moderate and high concentrations of PA103 (107 and 109 CFU/ml)
showed significantly higher levels of cytotoxicity after 2 h and
caused a 100% loss of viability within 4 h. A low concentration (105 CFU/ml) of PAO1 did not show cytotoxicity. A moderate
concentration of PAO1 (107 CFU/ml) caused a 10% loss of
viability over a 6-h period. A high concentration of PAO1
(109 CFU/ml) led to moderate cytotoxicity (30% loss of
viability) after 6 h of coculture. Finally, a low concentration
(105 CFU/ml) of 6294 did not lead to cytotoxicity. A
moderate concentration (107 CFU/ml) of 6294 caused only a
10% loss of viability, and a high concentration (109
CFU/ml) of 6294 caused a 90% loss of viability over a 6-h incubation period. These results indicated that higher bacterial inocula and
longer incubation periods may be required for strains not possessing
exoU to induce cytotoxicity.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 1.
Cytotoxicities of P. aeruginosa strains to
lung epithelial cells. Cytotoxicities of P. aeruginosa
strains to lung bronchial cells were evaluated by an assay measuring
LDH release from the cells. Human bronchial cells immortalized by SV40
(BEAS-2B) (2 × 104 cells) were cocultured with one of
three different P. aeruginosa strains (PA103, PAO1, or 6294)
at three different concentrations (109, 107,
and 105 CFU/ml) for 6 h. LDH activities were measured
at 2-h intervals. Values are the averages of three assays and are shown
as means ± standard deviations (indicated by error bars).
***, P < 0.001 compared to the values at time
zero.
|
|
Lung injury after the instillation of the three different P. aeruginosa strains.
We examined the in vivo toxicities of
the three P. aeruginosa strains (PA103, PAO1, and 6294) in
mice by using an acute lung infection model. Three different doses of
these strains were again utilized. Figure
2A shows the efflux of the airspace
protein tracer into blood 4 h after the particular bacterial
strain had been instilled. The efflux of the airspace protein tracer
has been shown to be indicative of the quantity of lung epithelial
injury (17, 32, 33). The instillation of moderate and high
doses of PA103 led to significant quantities of tracer leakage from the
airspaces of the instilled lungs into the circulation. The instillation
of the small and moderate doses of PAO1 (105 and
107 CFU/ml) did not cause epithelial injury; only the
instillation of the highest dose of PAO1 (109 CFU/ml)
caused any appreciable efflux of the airspace protein tracer into the
circulation. The instillation of the small and moderate doses of 6294 (105 and 107 CFU/ml) did not cause significant
efflux of the airspace protein tracer into the circulation. However,
the instillation of the highest dose of 6294 (109 CFU/ml)
was associated with a significant efflux of the airspace protein tracer
into the circulation. Therefore, only instillation of the largest dose
(109 CFU/ml) of the two invasive strains led to lung
epithelial injury, with 6294 causing more epithelial injury than PAO1.

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 2.
Measurement of lung epithelial damage and edema. Inocula
(50 µl each) were prepared with no bacteria, PA103, PAO1, or 6294 at
three different concentrations (105, 107, and
109 CFU/ml). An inoculum was instilled into one lung with a
protein tracer consisting of 125I-labeled human albumin.
(A) Lung protein tracer leakage into blood. (B) Wet/dry ratios of lungs
4 h after bacterial instillation. Data are means ± standard
deviations (indicated by error bars). Plus signs indicate statistical
significances of intragroup comparisons relative to the group treated
with the lowest dose of the same bacteria (+, P < 0.05; ++, P < 0.01; +++, P < 0.001).
Asterisks indicate statistical significances of comparisons between the
experimental groups and the control group (*, P < 0.05; **, P < 0.01; ***, P < 0.001). Each group consisted of three to five mice. One-way analysis
of variance and the Bonferroni test were used to determine statistical
significances.
|
|
The wet/dry ratios of lungs have been utilized as a measurement of lung
edema. Figure
2B demonstrates the wet/dry ratios of
the lungs 4 h
after instillation of the three strains at the three
different doses.
There were no significant increases of the wet/dry
ratios after the
instillation of the lowest dose (10
5 CFU/ml) of any of the
three strains; rather, the instillation
of the low dose of 6294 decreased the ratio significantly. The
instillation of the moderate and
high doses (10
7 and 10
9 CFU/ml) of PA103 caused
significant increases in the wet/dry
ratios. In contrast, the
instillation of the highest dose (10
9 CFU/ml) of PAO1 did
not cause a significant increase in the wet/dry
ratio. The instillation
of the highest dose (10
9 CFU/ml) of 6294 did lead to a
significant increase in the wet/dry
ratios of the lungs compared with
the lowest dose of 6294, but
the increase was not as large as that seen
after the instillation
of the highest dose of PA103.
Bacterial dissemination after the instillation of the three
different P. aeruginosa strains.
Bacterial cultures of
blood, pleural fluids, and livers are shown in Fig.
3. The instillation of all doses of PA103
led to dissemination of bacteria into the blood and livers of the
infected animals. Pleural fluids were shown to be infected when the two highest doses of PA103 were used. In contrast, only the instillation of
the highest dose of PAO1 caused significant dissemination to blood, the
liver, or the pleural space. Only the instillation of the highest dose
of 6294 led to dissemination, but the percentages of positive blood and
liver cultures were larger than those seen after the instillation of
the highest dose of PAO1.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 3.
Bacterial dissemination 4 h after the instillation
of P. aeruginosa. Inocula (50 µl each) containing no
bacteria, PA103, PAO1, or 6294 were instilled in lungs at three
different concentrations (105, 107, and
109 CFU/ml). Disseminations of bacteria into the blood,
pleural fluid, and liver 4 h after instillation were compared
among the three different P. aeruginosa strains. Data are
ratios of quantitative bacterial cultures from three to five mice.
Fisher's exact test was used for comparison with the control group
(data not shown; no positive blood, pleural fluid, or liver cultures
for five mice). Asterisks indicate P values as described in the legend
to Fig. 2.
|
|
Histology of the bacterium-instilled lungs.
To obtain
information on the type of tissue damage caused by each bacterial
infection, histologic sections were obtained 4 h after the
instillation of the three bacterial strains at three different doses.
Figure 4 shows the results from the
control mice that received the instillate without bacteria (Fig. 4A)
and from the mice that received the highest dose (109
CFU/ml) of the three different P. aeruginosa strains (Fig.
4B, C, and D). Destruction of alveolar structures was observed in the
sections obtained from the mice instilled with the highest dose of
PA103. Fewer neutrophils were seen in sections from the lungs of
animals which received the highest dose of PA103 compared to the number
seen in sections from animals which had received PAO1 or 6294. In
contrast, the lung destruction was least severe in the mice instilled
with PAO1. The sections obtained from the mice instilled with the
highest dose of 6294 showed large amounts of neutrophil infiltration
into the airspaces and more lung destruction than that seen after the
same dose of PAO1.

View larger version (111K):
[in this window]
[in a new window]
|
FIG. 4.
Lung histology 4 h after the instillation of three
different P. aeruginosa strains at the highest dose
(109 CFU/ml). An inoculum (50 µl) consisting of no
bacteria (A), PA103 (B), PAO1 (C), or 6294 (D) was instilled into one
lung. Four hours after the instillation, the lungs were perfused with a
10% buffered formalin solution for fixation and paraffin sections were
made for hematoxylin-eosin staining.
|
|
Mortality in mice instilled with the three different P. aeruginosa strains.
Survival studies were performed for mice
instilled with the three strains, PA103, PAO1 and 6294, at the three
different doses (Table 1). Mice infected
with PA103 had the highest mortality rate; all the mice died after the
instillation of the moderate or the high dose. In contrast, none of the
mice died after the instillation of the moderate dose of 6294 or PAO1.
However, mice that received the highest dose of 6294 died sooner than
did mice that received the highest dose of PAO1.
Correlation between lung epithelial injury and both cytotoxicity
and mortality due to infection with P. aeruginosa.
Figure
5A shows the correlation between
cytotoxicity (Fig. 1) and lung epithelial injury (as measured by
protein tracer leakage) (Fig. 2). Conditions which led to high
cytotoxicity in vitro also showed large quantities of lung protein
tracer leakage in vivo. We concluded that cytotoxicity in vitro
correlated with the production of severe lung epithelial injury. Figure
5B shows the correlation between mortality of the mice within 24 h
(Table 1) and lung epithelial injury as measured by the protein tracer
leakage (Fig. 2). These data showed a positive correlation between
mortality and epithelial injury. Thus, cytotoxicity in vitro appears to be a good predictor of the capability of bacterial strains to injure
the epithelium in vivo, which in turn correlates with an increased
probability of a fatal infection.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 5.
Correlation between lung epithelial injury and both
cytotoxicity and mortality. (A) Correlation between lung protein tracer
leakage (data from Fig. 2A) and cytotoxicity (data from Fig. 1) was
calculated. (B) Correlation between lung protein tracer leakage (data
from Fig. 2A) and mortality of mice within 24 h (data from Table
1) was calculated. Data are means ± standard deviations
(indicated by error bars). The linear regressions were calculated with
the regression coefficients.
|
|
Production of the autoinducer PAI-1.
We reasoned that
density-induced cytotoxicity may result from the expression of
virulence determinants coordinately regulated by the P. aeruginosa quorum-sensing systems. To examine this hypothesis, the
different levels of production of the autoinducer PAI-1 from the
overnight cultures of the three different P. aeruginosa
strains were compared utilizing the lasR
lasB::lacZ plasmids in E. coli (Fig. 6A).
-Galactosidase activities
induced by the autoinducer were the highest in culture medium from
6294; PAO1 cultures expressed less autoinducer as measured by
-galactosidase activity, and culture medium from the cytotoxic
strain PA103 did not induce any
-galactosidase activity. In contrast
to the results obtained when bacterial culture medium was assayed,
cocultivation of the three different P. aeruginosa strains
with human bronchial cells showed a different pattern. After 4 h,
the cell culture medium with PAO1 expressed the highest level of
autoinducer activity (Fig. 6B). Cocultivation of PA103 with BEAS cells
over the 4-h period did not result in the production of autoinducer
activity.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
Production of the autoinducer PAI-1 in culture. (A) The
bioactivity of PAI-1 in the culture medium from each P. aeruginosa strain was measured as the ability to activate LasR in
a -galactosidase reporter construct with the lasB
promoter. Supernatants from bacterial cultures of PA103, PAO1, or 6294 were added in the relative amounts shown on the horizontal axis. (B)
Bioactivities of PAI-1 in the culture medium of human bronchial cells
exposed to three different P. aeruginosa strains at three
different concentrations for 4 h. Data are means ± standard
deviations (indicated by error bars). *, P < 0.05;
**, P < 0.01; ***, P < 0.001 (relative to the negative-control group [no extract for
experiment in panel A, no bacteria for experiment in panel B]).
One-way analysis of variance and the Bonferroni test were used to
determine statistical significances.
|
|
Proteinase production.
PA103 at a concentration of
109 CFU/ml in the presence of BEAS cells synthesizes
alkaline protease (AprA) but not elastase (LasB) (Fig.
7A). In addition, gelatinase A (MMP-2, 72 kDa), a proteinase constitutively synthesized by BEAS cells (Fig. 7D) was detected. PAO1 required the presence of the BEAS cells to synthesize alkaline protease and elastase. Elastase was detected only
when 109 CFU of PAO1/ml was added (Fig. 7B). At both
109 and 107 CFU/ml, 6294 synthesized more
alkaline protease and elastase in the presence of the BEAS cells than
in medium alone (Fig. 7C). Both proteases were detected when
109 CFU of 6294/ml was incubated in medium alone but not
when 107 CFU/ml was used alone. An unknown protease with a
molecular mass of 85 kDa was detected in the medium containing
109 CFU of 6294/ml plus BEAS cells.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 7.
Proteinase production by BEAS cells and P. aeruginosa. Proteinase activities present in culture medium
containing of 109, 107, or 105 CFU
of PA103/ml (A and D), PAO1 (B, D, and E), and 6294 (C, D, and E) with
(+) and without ( ) BEAS cells were visualized by gelatin zymography.
Samples containing 1.5 µl (*), 15 µl (**), and 4 µl
(***) of medium were electrophoresed on SDS-8% polyacrylamide
gels containing 0.2% gelatin. Following electrophoresis, the gels were
incubated overnight in cleavage buffer, and the cleaved bands were
visualized by negative staining with Coomassie brilliant blue. LasB,
P. aeruginosa-encoded elastase; AprA, P. aeruginosa-encoded alkaline protease; GelA, gelatinase A (MMP2
encoded by BEAS cells). (F) Elastase standard.
|
|
In medium taken from the BEAS cells exposed to bacteria, the largest
amount of 6294 (10
9 CFU/ml) produced about 25-fold more
elastase than was produced
in the medium from these cells exposed to
the same concentration
of PAO1 organisms. The enhancement of elastase
production was
measured in Western blots (498 ± 65 pg/10
9 CFU of 6294 versus 21 ± 7 pg/10
9
CFU of PAO1) and by zymographic analysis (Fig.
7B, C, and E).
At the
lowest concentration, 10
5 CFU/ml of PA103, PAO1, or 6294, the only protease detected was
gelatinase A synthesized by the BEAS
cells (Fig.
7D). This proteinase
was present in all samples but is not
visible in Fig.
7B or C
because of the amount of sample that was
loaded.
 |
DISCUSSION |
In pneumonia, the integrity of the epithelial barrier of the lung
is critical for protection from dissemination of airspace bacteria.
Experimentally, only a few agents have been found that cause severe
lung epithelial injury (32). We reported that lung epithelial injury was caused by the airspace instillation of live P. aeruginosa (4 × 109 to 10 × 109 CFU of the clinical isolate Fisher immunotype I) in
sheep but not by the airspace instillation of large doses of E. coli endotoxin (32, 33). The severities of lung
epithelial injury caused by the various P. aeruginosa
strains have been shown to be different (17); we have
previously shown that the production of ExoU by PA103 and other
cytotoxic strains was responsible for cytotoxicity and lung injury
(10). The present experiments again verify that the
cytotoxicity of PA103 is independent of proteinase production.
In the present study, we investigated the cytotoxicity seen after the
application or instillation of two invasive strains, 6294 and PAO1, and
compared the results to that seen after the application or instillation
of the same dose of a cytotoxic strain, PA103. We replicated our
previous results in that the instillation of low and moderate doses of
these two invasive strains did not cause either significant
cytotoxicity in vitro or lung injury in vivo (13). However,
the instillation of large doses of the invasive strains, especially
6294, caused cytotoxicity and lung injury and the demise of the animals
from dissemination of bacteria.
P. aeruginosa 6294 has been classified as an invasive strain
due to the lack of exoU. This strain, however, appears to
possess the LasR-LasI quorum-sensing modules, similar to strain PAO1. The production of PAI-1 in the overnight bacterial culture medium containing 6294 was greater than that in the culture medium containing PAO1. Notably, the application of these bacteria onto epithelial cells
altered their production of the autoinducers; PAO1 produced more PAI-1
than 6294 did in the presence of the epithelial cells. Increases in
LasB did not correlate with the production of PAI-1 by 6294. Therefore,
the production of PAI-1 did not explain the increase in the production
of elastase by strain 6294 compared to that by PAO1.
Recently, several quorum-sensing systems including the RhlR-RhlI system
have been described; the amount of LasB produced by 6294 may be
influenced by this second system (2, 19). On the other hand,
the increased production of elastase by 6294 compared to that produced
by PAO1 could be due to differences in other regulatory or sensory
components in 6294. Although we previously demonstrated that elastase
production was not associated with lung epithelial injury
(17), the present results indicate that large doses of
bacteria correlate with the enhanced production of virulence
determinants regulated by quorum sensing (LasB and LasI) and are
therefore markers of other virulence factors. We have also shown that
the levels of LasB production correlate with increased cytotoxicity and
lung epithelial injury associated with a clinical isolate. Taken
together these observations may explain the wide variations in
exoproduct production observed when different P. aeruginosa
strains are used in different in vitro and in vivo model systems. Thus,
exoproduct production is a function of the genetic makeup of the
particular P. aeruginosa strain and changes in expression
may be due to direct and indirect differences in gene expression and
secretion.
Despite the complexity of factors involved in P. aeruginosa-induced lung pathology, we found that the quantitative
experiments measuring cytotoxicity in vitro accurately predicted the in
vivo lung injury and mortality results (Fig. 5). However, a large range of bacterial concentrations and incubation periods had to be utilized to obtain accurate correlations. Notably, cytotoxic factors and virulence in the lung were inversely correlated with autoinducer PAI-1
production in vitro, particularly when PAI-1 was measured in the
supernatants of bacteria exposed to cultured cells (Fig. 6). PAI-1 also
appeared to increase the recruitment of polymorphonuclear leukocytes to
the infected airspaces (Fig. 4) and, therefore, increase the
elimination of bacteria from the lung. PAI-1 may promote cytokine
production (interleukin-8 or other chemoattractants, see below) that
produced the leukocyte recruitment to the infected lungs and thereby
may cause the difference in pathology noted between these three
infections.
There are reports that P. aeruginosa exoproducts
(20) and the P. aeruginosa autoinducer PAI-1
(6) stimulate interleukin-8 production in human respiratory
epithelial cells. The histological results from the present study
suggest that neutrophil infiltration was most significant in the lungs
of the animals which had received the highest dose of 6294. Neutrophils
might have contributed to the lung injury in these animals. In
contrast, there were very few neutrophils in the sections obtained from
the animals exposed to the highest dose of PA103; these results suggest
that the exoproducts from PA103 are directly responsible for the lung
epithelial damage and that either the resultant edema dilutes the
neutrophil infiltration or PA103 inhibits neutrophil infiltration in
some manner.
The lung injury assessments suggest that PA103 caused the most severe
lung injury and the most dissemination compared to the comparable doses
of PAO1 and 6294. The instillation of the highest dose of 6294 did lead
to bacterial dissemination to the liver that was similar to that seen
with the same dose of PA103. However, the instillation of the highest
dose of PAO1 led to only 50% of the bacterial dissemination of the
other strains. Although the instillation of the largest dose of any of
these bacterial strains led to the demise of the mice within 3 days, a
high dose of PA103 or 6294 led to much faster animal death than did
such a dose of PAO1. As the lung edema and lung epithelial injury seen
in the mice instilled with PAO1 were not severe even after exposure to the highest dose, these results suggest mortality is determined by the
ability of the bacteria to damage the lung epithelium enough to
disseminate.
In conclusion, although P. aeruginosa strains have been
recently characterized as to their cytotoxicities or invasiveness based
on the presence of a functional exoU allele, we found that the application or instillation of an invasive strain, especially 6294, led to cytotoxicity and severe lung epithelial injury depending on
bacterial density. Although elastase does not cause cytotoxicity of the
lung epithelium, its elaboration by the invasive 6294 strain was a
marker for other virulence factors. Our results suggest that strains
that produced the most PAI-1 were the least virulent in vitro as well
as in vivo and that the production of PAI-1 may increase neutrophil
recruitment to the infected lungs. LasI and autoinducer have been
recently shown to be required for biofilm production (5). As
the requirements for biofilm production are markedly different than the
requirements for bacterial dissemination, it is reasonable that the
LasI pathway may be inversely regulated relative to the pathways that
regulate dissemination (i.e., ExsA). Although there are clearly
multiple mechanisms for the induction of cytotoxicity and mortality in
vivo, quantitative measurements of cytotoxicity in vitro were accurate
predictors of cytotoxicity and mortality in vivo when a wide range of
concentrations of bacteria were utilized.
 |
ACKNOWLEDGMENTS |
This work was supported by National Heart and Lung Institute
award HL49810 (J.P.W.-K.), National Institute of Allergy and Infectious
Disease awards AI31665 and AI01289 (D.W.F.) and EY06663 (S.S.T.).
We thank Richard Shanks for his technical assistance and E. P. Greenberg, Department of Microbiology, University of Iowa, Iowa City,
for providing E. coli MG4 and for suggestions concerning the
autoinducer assay.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Anesthesia and Critical Care Medicine, The University of California, San Francisco, CA 94143. Phone: (415) 476-8968. Fax: (415) 476-5434. E-mail: jwk{at}jemo.ucsf.edu.
Editor: E. I. Tuomanen
 |
REFERENCES |
| 1.
|
Brewer, S. C.,
R. G. Wunderink,
C. B. Jones, and K. V. Leeper, Jr.
1996.
Ventilator-associated pneumonia due to Pseudomonas aeruginosa.
Chest
109:1019-1029[Abstract/Free Full Text].
|
| 2.
|
Brint, J. M., and D. E. Ohman.
1995.
Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family.
J. Bacteriol.
177:7155-7163[Abstract/Free Full Text].
|
| 3.
|
Burnette, W. N.
1981.
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.
Anal. Biochem.
112:195-203[Medline].
|
| 4.
|
Craven, D. E., and K. Steger.
1996.
Nosocomial pneumonia in mechanically ventilated adult patients: epidemiology and prevention in 1996.
Semin. Respir. Infect.
11:32-53[Medline].
|
| 5.
|
Davies, D. G.,
M. R. Parsek,
J. P. Pearson,
B. H. Iglewski,
J. W. Costerton, and E. P. Greenberg.
1998.
The involvement of cell-to-cell signals in the development of a bacterial biofilm.
Science
280:295-298[Abstract/Free Full Text].
|
| 6.
|
Dimango, E.,
H. J. Zar,
R. Bryan, and A. Prince.
1995.
Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8.
J. Clin. Invest.
96:2204-2210.
|
| 7.
|
Dunn, M.,
G. Richard, and G. Wundderink.
1995.
Ventilator-associated pneumonia caused by Pseudomonas infection.
Clin. Chest Med.
16:95-109[Medline].
|
| 8.
|
Fabregas, N.,
A. Torres,
M. El-Ebiary,
J. Ramfrez,
C. Hernandez,
J. Gonzalez,
J. P. de la Bellacasa,
J. de Anta, and R. Rodriguez-Roisin.
1996.
Histopathologic and microbiologic aspects of ventilator-associated pneumonia.
Anesthesiology
84:760-771[Medline].
|
| 9.
|
Fagon, J. Y.,
J. Chastre,
A. J. Hance,
P. Montravers,
A. Novara, and C. Gilbert.
1993.
Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.
Am. J. Med.
94:281-288[Medline].
|
| 10.
|
Finck-Barbancon, V.,
J. Goranson,
L. Zhu,
T. Sawa,
J. P. Wiener-Kronish,
S. M. J. Fleiszig,
C. Wu,
L. Mende-Mueller, and D. W. Frank.
1997.
ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Mol. Microbiol.
25:547-557[Medline].
|
| 11.
|
Fleiszig, S. M. J.,
T. S. Zaidi, and G. B. Pier.
1995.
Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro.
Infect. Immun.
63:4072-4077[Abstract].
|
| 12.
|
Fleiszig, S. M. J.,
T. S. Zaidi,
M. J. Preston,
M. Grout,
D. J. Evans, and G. B. Pier.
1996.
Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa.
Infect. Immun.
64:2288-2294[Abstract].
|
| 13.
|
Fleiszig, S. M. J.,
J. P. Wiener-Kronish,
H. Miyazaki,
V. Vallas,
K. E. Mostov,
D. Kanada,
T. Sawa,
T. S. B. Yen, and D. W. Frank.
1997.
Cytotoxic and invasive strains of Pseudomonas aeruginosa are genotypically distinct at the loci encoding exoenzyme S.
Infect. Immun.
65:579-586[Abstract].
|
| 14.
|
Fuqua, C.,
S. C. Winans, and E. P. Greenberg.
1996.
Census and consensus in bacteria ecosystems: LuxR-LuxI family of quorum-sensing transcriptional regulators.
Annu. Rev. Microbiol.
50:727-751[Medline].
|
| 15.
|
Gambello, M. J., and B. H. Iglewski.
1991.
Cloning and characterization of Pseudomonas aeruginosa lasR gene. A transcriptional activator of elastase expression.
J. Bacteriol.
173:3000-3009[Abstract/Free Full Text].
|
| 16.
|
Gambello, M. J.,
S. Kaye, and B. H. Iglewski.
1993.
LasR of Pseudomonas aeruginosa is a transcriptional activator of the alkaline protease gene (apr) and an enhancer of exotoxin A expression.
Infect. Immun.
61:1180-1184[Abstract/Free Full Text].
|
| 17.
|
Kudoh, I.,
J. P. Wiener-Kronish,
S. Hashimoto,
J. F. Pittet, and D. Frank.
1994.
Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury.
Am. J. Physiol.
267:L551-L556[Abstract/Free Full Text].
|
| 18.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 19.
|
Latifi, A.,
M. K. Winson,
M. Foglino,
B. W. Bycroft,
G. S. A. B. Stewart,
A. Lazdunski, and P. Williams.
1995.
Multiple homologues of LuxR and LuxI control expression of virulence determinants and secondary metabolites through quorum sensing in Pseudomonas aeruginosa PAO1.
Mol. Microbiol.
17:333-343[Medline].
|
| 20.
|
Massion, P.,
H. Inoue,
J. Richman-Eisenstat,
D. Grunberger,
P. G. Jorens,
B. Houssel,
J. P. Wiener-Kronish, and J. Nadel.
1994.
Novel Pseudomonas product stimulates interleukin-8 production in airway epithelial cells in vitro.
J. Clin. Invest.
93:26-32.
|
| 21.
|
Miller, J. A.
1976.
Experiments in molecular genetics, p. 352-355.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 22.
|
Parrillo, J. E.,
M. M. Parker,
C. Nathanson,
A. F. Suffredini,
R. L. Danner,
R. E. Cunnion, and F. P. Ognibene.
1990.
Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy.
Ann. Intern. Med.
113:227-237.
|
| 23.
|
Passador, L.,
J. M. Cook,
M. J. Gambello,
L. Rust, and B. H. Iglewski.
1993.
Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell communication.
Science
260:1127-1130[Abstract/Free Full Text].
|
| 24.
|
Pearson, J. P.,
K. M. Gray,
L. Passador,
K. D. Tucker,
A. Eberhard,
B. H. Igelwski, and E. P. Greenberg.
1994.
Structure of the autoinducer required for expression of Pseudomonas aeruginosa virulence genes.
Proc. Natl. Acad. Sci. USA
91:197-201[Abstract/Free Full Text].
|
| 25.
|
Preston, M. J.,
S. M. J. Fleiszig,
T. S. Zaidi,
J. B. Goldberg,
V. D. Shortridge,
M. L. Vasil, and G. B. Pier.
1995.
Rapid and sensitive method for evaluating Pseudomonas aeruginosa virulence factors during corneal infections in mice.
Infect. Immun.
63:3497-3501[Abstract].
|
| 26.
|
Rouby, J. J.
1996.
Nosocomial infection in the critically ill. The lung as a target organ.
Anesthesiology
84:757-758[Medline].
|
| 27.
|
Rouby, J. J.
1996.
Histology and microbiology of ventilator-associated pneumonias.
Semin. Respir. Infect.
11:54-61[Medline].
|
| 28.
|
Tang, H. B.,
E. Dimango,
R. Bryan,
M. J. Gambello,
B. H. Igelwski,
J. B. Goldberg, and A. Prince.
1996.
Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection.
Infect. Immun.
64:37-43[Abstract].
|
| 29.
|
Taylor, G. D.,
M. Buchanan-Chell,
T. Kirkland,
M. McKenzie, and R. Wiens.
1994.
Bacteremic nosocomial pneumonia. A 7-year experience in one institution.
Chest
108:786-788[Abstract/Free Full Text].
|
| 30.
|
Torres, A.,
R. Aznar,
J. M. Gatell,
P. Jimenez,
J. Gonzalez,
A. Ferrer,
R. Celis, and R. Rodriguez-Roisin.
1990.
Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients.
Am. Rev. Respir. Dis.
142:523-528[Medline].
|
| 31.
|
Twining, S. S.,
X. Zhou,
D. P. Schulte,
P. M. Wilson,
B. Fish, and J. Moulder.
1996.
Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
Investig. Ophthalmol. Vis. Sci.
37:511-522[Abstract/Free Full Text].
|
| 32.
|
Wiener-Kronish, J. P.,
K. H. Albertine, and M. A. Matthay.
1991.
Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin.
J. Clin. Invest.
88:864-875.
|
| 33.
|
Wiener-Kronish, J. P.,
T. Sakuma,
I. Kudoh,
J. F. Pittet,
D. Frank,
L. Dobbs,
M. L. Vasil, and M. Matthay.
1993.
Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits.
J. Appl. Physiol.
75:1661-1669[Abstract/Free Full Text].
|
| 34.
|
Wunderink, R. G.
1995.
Ventilator-associated pneumonia. Failure to respond to antibiotics therapy.
Clin. Chest Med.
16:173-193[Medline].
|
Infect Immun, July 1998, p. 3242-3249, Vol. 66, No. 7
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
El Solh, A. A., Alhajhusain, A.
(2009). Update on the treatment of Pseudomonas aeruginosa pneumonia. J Antimicrob Chemother
64: 229-238
[Abstract]
[Full Text]
-
Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerova, M., Guery, B. P., Faure, K.
(2009). Role of LecA and LecB Lectins in Pseudomonas aeruginosa-Induced Lung Injury and Effect of Carbohydrate Ligands. Infect. Immun.
77: 2065-2075
[Abstract]
[Full Text]
-
Baer, M., Sawa, T., Flynn, P., Luehrsen, K., Martinez, D., Wiener-Kronish, J. P., Yarranton, G., Bebbington, C.
(2009). An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity. Infect. Immun.
77: 1083-1090
[Abstract]
[Full Text]
-
Ganter, M. T., Roux, J., Su, G., Lynch, S. V., Deutschman, C. S., Weiss, Y. G., Christiaans, S. C., Myazawa, B., Kipnis, E., Wiener-Kronish, J. P., Howard, M., Pittet, J.-F.
(2009). Role of Small GTPases and {alpha}v{beta}5 Integrin in Pseudomonas aeruginosa-Induced Increase in Lung Endothelial Permeability. Am. J. Respir. Cell Mol. Bio.
40: 108-118
[Abstract]
[Full Text]
-
Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Hoiby, N., Givskov, M.
(2008). Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa. Antimicrob. Agents Chemother.
52: 3648-3663
[Abstract]
[Full Text]
-
Diaz, M. H., Shaver, C. M., King, J. D., Musunuri, S., Kazzaz, J. A., Hauser, A. R.
(2008). Pseudomonas aeruginosa Induces Localized Immunosuppression during Pneumonia. Infect. Immun.
76: 4414-4421
[Abstract]
[Full Text]
-
El Solh, A. A., Akinnusi, M. E., Wiener-Kronish, J. P., Lynch, S. V., Pineda, L. A., Szarpa, K.
(2008). Persistent Infection with Pseudomonas aeruginosa in Ventilator-associated Pneumonia. Am. J. Respir. Crit. Care Med.
178: 513-519
[Abstract]
[Full Text]
-
Imamura, Y., Yanagihara, K., Fukuda, Y., Kaneko, Y., Seki, M., Izumikawa, K., Miyazaki, Y., Hirakata, Y., Sawa, T., Wiener-Kronish, J. P., Kohno, S.
(2007). Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model. Eur Respir J
29: 965-968
[Abstract]
[Full Text]
-
Cuzick, A., Stirling, F. R., Lindsay, S. L., Evans, T. J.
(2006). The Type III Pseudomonal Exotoxin U Activates the c-Jun NH2-Terminal Kinase Pathway and Increases Human Epithelial Interleukin-8 Production. Infect. Immun.
74: 4104-4113
[Abstract]
[Full Text]
-
Rabin, S. D. P., Veesenmeyer, J. L., Bieging, K. T., Hauser, A. R.
(2006). A C-Terminal Domain Targets the Pseudomonas aeruginosa Cytotoxin ExoU to the Plasma Membrane of Host Cells.. Infect. Immun.
74: 2552-2561
[Abstract]
[Full Text]
-
Shaver, C. M., Hauser, A. R.
(2006). Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals. Microbiology
152: 143-152
[Abstract]
[Full Text]
-
Quinaud, M., Chabert, J., Faudry, E., Neumann, E., Lemaire, D., Pastor, A., Elsen, S., Dessen, A., Attree, I.
(2005). The PscE-PscF-PscG Complex Controls Type III Secretion Needle Biogenesis in Pseudomonas aeruginosa. J. Biol. Chem.
280: 36293-36300
[Abstract]
[Full Text]
-
Ader, F., Le Berre, R., Faure, K., Gosset, P., Epaulard, O., Toussaint, B., Polack, B., Nowak, E., Viget, N. B., Kipnis, E., Guery, B. P.
(2005). Alveolar Response to Pseudomonas aeruginosa: Role of the Type III Secretion System. Infect. Immun.
73: 4263-4271
[Abstract]
[Full Text]
-
Lee, V. T., Smith, R. S., Tummler, B., Lory, S.
(2005). Activities of Pseudomonas aeruginosa Effectors Secreted by the Type III Secretion System In Vitro and during Infection. Infect. Immun.
73: 1695-1705
[Abstract]
[Full Text]
-
Kurahashi, K., Ota, S., Nakamura, K., Nagashima, Y., Yazawa, T., Satoh, M., Fujita, A., Kamiya, R., Fujita, E., Baba, Y., Uchida, K., Morimura, N., Andoh, T., Yamada, Y.
(2004). Effect of lung-protective ventilation on severe Pseudomonas aeruginosa pneumonia and sepsis in rats. Am. J. Physiol. Lung Cell. Mol. Physiol.
287: L402-L410
[Abstract]
[Full Text]
-
Denervaud, V., TuQuoc, P., Blanc, D., Favre-Bonte, S., Krishnapillai, V., Reimmann, C., Haas, D., van Delden, C.
(2004). Characterization of Cell-to-Cell Signaling-Deficient Pseudomonas aeruginosa Strains Colonizing Intubated Patients. J. Clin. Microbiol.
42: 554-562
[Abstract]
[Full Text]
-
Lesprit, P., Faurisson, F., Join-Lambert, O., Roudot-Thoraval, F., Foglino, M., Vissuzaine, C., Carbon, C.
(2003). Role of the Quorum-sensing System in Experimental Pneumonia due to Pseudomonas aeruginosa in Rats. Am. J. Respir. Crit. Care Med.
167: 1478-1482
[Abstract]
[Full Text]
-
Faure, K., Shimabukuro, D., Ajayi, T., Allmond, L. R., Sawa, T., Wiener-Kronish, J. P.
(2003). O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa. J. Clin. Microbiol.
41: 2158-2160
[Abstract]
[Full Text]
-
Jacob, T., Lee, R. J., Engel, J. N., Machen, T. E.
(2002). Modulation of Cytosolic Ca2+ Concentration in Airway Epithelial Cells by Pseudomonas aeruginosa. Infect. Immun.
70: 6399-6408
[Abstract]
[Full Text]
-
Shime, N., Sawa, T., Fujimoto, J., Faure, K., Allmond, L. R., Karaca, T., Swanson, B. L., Spack, E. G., Wiener-Kronish, J. P.
(2001). Therapeutic Administration of Anti-PcrV F(ab')2 in Sepsis Associated with Pseudomonas aeruginosa. J. Immunol.
167: 5880-5886
[Abstract]
[Full Text]
-
Finck-Barbancon, V., Frank, D. W.
(2001). Multiple Domains Are Required for the Toxic Activity of Pseudomonas aeruginosa ExoU. J. Bacteriol.
183: 4330-4344
[Abstract]
[Full Text]
-
Garrity-Ryan, L., Kazmierczak, B., Kowal, R., Comolli, J., Hauser, A., Engel, J. N.
(2000). The Arginine Finger Domain of ExoT Contributes to Actin Cytoskeleton Disruption and Inhibition of Internalization of Pseudomonas aeruginosa by Epithelial Cells and Macrophages. Infect. Immun.
68: 7100-7113
[Abstract]
[Full Text]
-
Allewelt, M., Coleman, F. T., Grout, M., Priebe, G. P., Pier, G. B.
(2000). Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread. Infect. Immun.
68: 3998-4004
[Abstract]
[Full Text]
-
Pearson, J. P., Feldman, M., Iglewski, B. H., Prince, A.
(2000). Pseudomonas aeruginosa Cell-to-Cell Signaling Is Required for Virulence in a Model of Acute Pulmonary Infection. Infect. Immun.
68: 4331-4334
[Abstract]
[Full Text]
-
Dean, C. R., Franklund, C. V., Retief, J. D., Coyne, M. J. Jr., Hatano, K., Evans, D. J., Pier, G. B., Goldberg, J. B.
(1999). Characterization of the Serogroup O11 O-Antigen Locus of Pseudomonas aeruginosa PA103. J. Bacteriol.
181: 4275-4284
[Abstract]
[Full Text]
-
Comolli, J. C., Waite, L. L., Mostov, K. E., Engel, J. N.
(1999). Pili Binding to Asialo-GM1 on Epithelial Cells Can Mediate Cytotoxicity or Bacterial Internalization by Pseudomonas aeruginosa. Infect. Immun.
67: 3207-3214
[Abstract]
[Full Text]
-
Comolli, J. C., Hauser, A. R., Waite, L., Whitchurch, C. B., Mattick, J. S., Engel, J. N.
(1999). Pseudomonas aeruginosa Gene Products PilT and PilU Are Required for Cytotoxicity In Vitro and Virulence in a Mouse Model of Acute Pneumonia. Infect. Immun.
67: 3625-3630
[Abstract]
[Full Text]
-
Sawa, T., Kurahashi, K., Ohara, M., Gropper, M. A., Doshi, V., Larrick, J. W., Wiener-Kronish, J. P.
(1998). Evaluation of Antimicrobial and Lipopolysaccharide-Neutralizing Effects of a Synthetic CAP18 Fragment against Pseudomonas aeruginosa in a Mouse Model. Antimicrob. Agents Chemother.
42: 3269-3275
[Abstract]
[Full Text]